Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2020-03, Vol.20 (3), p.e137-e143
Hauptverfasser:	Chaulagain, Chakra P., Diacovo, Julia M., Elson, Leah, Comenzo, Raymond L., Samaras, Christy, Anwer, Faiz, Khouri, Jack, Landau, Heather, Valent, Jason
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Amyloidosis Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Daratumumab Humans Male Middle Aged Multiple myeloma Neoplasms, Plasma Cell - drug therapy Organ Transplantation - methods Plasmacytic post-transplant lymphoproliferative disorder Solid organ transplant Transplant Recipients - statistics & numerical data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!